In response to treatment, high-grade gliomas remodel the surrounding brain environment, creating interactions with nearby neurons and immune cells in ways that protect tumor cells and protect them from the body's natural defense.
Infiltrating gliomas are shaped by their genetic evolution and microenvironment, researchers report. The findings may help in the development of therapies to treat glioma brain tumors.
Study found no increased risk of developing brain tumors regardless of whether a person was a frequent cell phone user or if they had never used a cell phone before.
Cellular reprogramming of glioma cells into neural cells may be a promising treatment for glioblastoma brain cancer.
While incidence rates of malignant brain cancers have declined over recent years, the five-year survival rate for brain cancer patients remains low.
A new AI model can accurately classify a brain tumor of one of six common cancer types from a single MRI brain scan image.
Researchers found lymph-node-like structures close to glioma brain tumors in cancer patients. The study reveals immune cells within these structures can be activated to attack the brain tumor.
Researchers have carried out clinical trials to test a mutation-specific vaccine against malignant brain tumors. The vaccine has been found to be safe and effective in triggering the desired immune response in the brain cancer tumors.
Researchers have developed a Dp44mT nano-carrier that can directly target glioblastoma and other brain cancer cells.
Treating mouse models of astrocytomas with a new combination therapy resulted in tumor regression in 60% of the mice.
A new zebrafish model holds the potential for future studies of glioblastoma, an aggressive and lethal brain cancer.
Neurons and immune cells work together to promote tumor growth in neurofibromatosis type 1.
